The Care-Integrated Clinical Trials Act

Every patient's treatment can help the next patient. This proposed state law lets any patient get a screened, promising treatment through their own doctor, lets clinics charge enough to offer it, and publishes every result.

Millions of patients are waiting

7.4M
Americans with Alzheimer's
30M
Americans with a rare disease
2.1M
Americans diagnosed with cancer each year
95%
of rare diseases have no FDA-approved treatment

Why promising treatments go untested

No one pays to test old drugs
573
drugs proposed for Alzheimer's are mostly untested, because no company can profit from testing a drug it can't patent.
No one learns from patients
99.8%
of Alzheimer's patients are in no study, so nothing is learned from their treatment.
Right to Try gives makers no incentive
$0
profit allowed under Right to Try: makers may charge only their costs, so few offer their drugs.

What the act does

Review: An independent board approves each treatment, clinic and consent form.
Access: A treating doctor's documented recommendation and written consent are all a patient needs.
Payment: Clinics may charge for treatment. No insurer or state program has to pay.
Safety: Serious side effects are reported within five days, and an unresolved safety finding stops new patients.
Results: Every outcome is reported in one open format and published, de-identified.

A trial built into everyday care saved a million lives

In 2020, any UK hospital could enroll patients in RECOVERY during normal care, and outcomes came from routine records.

89 days
to show that a cheap steroid cuts deaths among the sickest COVID patients by up to a third. Typical trials take years.
4
treatments found that save lives, out of more than a dozen tested side by side.
$500
per patient, 82 times less than the $41,000 of a typical trial.